Kim, J.; Kim, J.-H.; Im, B.S.; Kim, G.H.; Chu, H.H.; Gwon, D.I.; Shin, J.H.; Shim, J.H.; Yoon, S.M.; Kim, S.
Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: An Inverse Probability of Treatment Weighted Analysis. Cancers 2026, 18, 33.
https://doi.org/10.3390/cancers18010033
AMA Style
Kim J, Kim J-H, Im BS, Kim GH, Chu HH, Gwon DI, Shin JH, Shim JH, Yoon SM, Kim S.
Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: An Inverse Probability of Treatment Weighted Analysis. Cancers. 2026; 18(1):33.
https://doi.org/10.3390/cancers18010033
Chicago/Turabian Style
Kim, Jihoon, Jin-Hyoung Kim, Byung Soo Im, Gun Ha Kim, Hee Ho Chu, Dong Il Gwon, Ji Hoon Shin, Ju Hyun Shim, Sang Min Yoon, and Sehee Kim.
2026. "Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: An Inverse Probability of Treatment Weighted Analysis" Cancers 18, no. 1: 33.
https://doi.org/10.3390/cancers18010033
APA Style
Kim, J., Kim, J.-H., Im, B. S., Kim, G. H., Chu, H. H., Gwon, D. I., Shin, J. H., Shim, J. H., Yoon, S. M., & Kim, S.
(2026). Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: An Inverse Probability of Treatment Weighted Analysis. Cancers, 18(1), 33.
https://doi.org/10.3390/cancers18010033
